Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (21-30 of 299) with videos related to

Pageof 30
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1991
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7H Stötter, M T Lotze
Research in Immunology|September 1, 1995
Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical applicationL Zitvogel, M T Lotze
Gene Therapy|March 1, 1995
Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancerH Tahara, M T Lotze
International Reviews of Immunology|March 20, 1998
Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunityM J Maeurer, M T Lotze
The Journal of Surgical Research|April 1, 1988
Derivation of cells with lytic activity against fresh and cultured tumors from human bone marrowD M Jablons, M T Lotze
The Journal of Clinical Investigation|May 3, 2000
Regulatable systems: applications in gene therapy and replicating virusesS Agha-Mohammadi, M T Lotze
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targetsR B Mailliard, M T Lotze
Oncology|March 1, 1994
Interleukin-2: solid-tumor therapyM H Oppenheim, M T Lotze
Lymphokine Research|January 1, 1986
Protocol design for lymphokine testing in clinical studies of human cancerM T Lotze, S A Rosenberg
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Report on the Keystone symposium: cellular immunity and the immunotherapy of cancer IIM T Lotze, O J Finn
Pageof 30

Showing results (21-30 of 299) with videos related to

Sort By:
Pageof 30
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1991
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7H Stötter, M T Lotze
Research in Immunology|September 1, 1995
Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical applicationL Zitvogel, M T Lotze
Gene Therapy|March 1, 1995
Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancerH Tahara, M T Lotze
International Reviews of Immunology|March 20, 1998
Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunityM J Maeurer, M T Lotze
The Journal of Surgical Research|April 1, 1988
Derivation of cells with lytic activity against fresh and cultured tumors from human bone marrowD M Jablons, M T Lotze
The Journal of Clinical Investigation|May 3, 2000
Regulatable systems: applications in gene therapy and replicating virusesS Agha-Mohammadi, M T Lotze
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targetsR B Mailliard, M T Lotze
Oncology|March 1, 1994
Interleukin-2: solid-tumor therapyM H Oppenheim, M T Lotze
Lymphokine Research|January 1, 1986
Protocol design for lymphokine testing in clinical studies of human cancerM T Lotze, S A Rosenberg
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Report on the Keystone symposium: cellular immunity and the immunotherapy of cancer IIM T Lotze, O J Finn
Pageof 30